OPS
CRNX icon

Orion Portfolio Solutions’s Crinetics Pharmaceuticals CRNX Stock Holding History

Orion Portfolio Solutions’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$593K Buy
17,680
+959
+6% +$35.8K 0.01% 1336
2024
Q4 		$855K Sell
16,721
-1,515
-8% -$84.8K 0.01% 1130
2024
Q3 		$932K Sell
18,236
-790
-4% -$40.7K 0.01% 1077
2024
Q2 		$852K Buy
19,026
+3,467
+22% +$160K 0.01% 1055
2024
Q1 		$728K Buy
+15,559
New +$609K 0.01% 1123

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orion Portfolio Solutions's CRNX Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Crinetics Pharmaceuticals (CRNX) stake by 5.7% in Q1 2025, buying an estimated $35.8K and bringing the position to 17,680 shares worth $593K. The position accounts for 0.01% of the portfolio, ranked #1336.

Orion Portfolio Solutions first reported a position in CRNX in Q1 2024 and has held it in 5 quarters since. The position peaked at $932K in Q3 2024. 227 funds tracked by Wall St. Rank hold CRNX as of Q1 2025.

  • Orion Portfolio Solutions held 17,680 shares of Crinetics Pharmaceuticals worth $593K as of Q1 2025.
  • Orion Portfolio Solutions bought 959 Crinetics Pharmaceuticals shares in Q1 2025, an estimated $35.8K.
  • Crinetics Pharmaceuticals made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1336 holding.
  • Orion Portfolio Solutions first reported a position in Crinetics Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Orion Portfolio Solutions's Crinetics Pharmaceuticals position peaked at $932K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.